KMC Systems Introduces KMC 360 Program of Contract Design, Manufacture and Maintenance Services
News Jun 12, 2009
Elbit Systems of America’s KMC Systems introduces KMC 360, the company’s complete program for contract design, manufacture and maintenance. The program is designed to support OEMs and start-ups throughout the entire medical device and instrumentation product lifecycle by centralizing all outsourcing support.
The company’s process streamlines communication, strengthens product quality and results in time-to-market advantages.
“Relying on multiple partners throughout a product’s lifecycle can result in market launch delays, increased costs and inefficiencies,” said Patrick W. McNallen, President, KMC Systems. “Just as a circle is all encompassing, so too is KMC Systems’ portfolio of services. Our customers work with one partner that has the relevant experience and skill set to develop, produce and maintain complex medical devices and instrumentation.”
KMC 360 helps medical companies bring quality products to market on time and on budget as well as reduce manufacturing and field service costs, which is especially critical in times of economic difficulty. The company’s approach is based on defined and proven processes, continual communication and cross-functional collaboration throughout each of the product lifecycle stages.
By allowing companies to work with one experienced partner, KMC 360 smoothes product transitions from design to manufacture, avoiding costly redesigns and delays. It also enhances field maintenance support by allowing end users to leverage KMC Systems’ intimate design knowledge of their systems gained through the design and manufacturing stages.
KMC Systems’ integrated process is ideal for in-vitro diagnostic, surgical, therapeutic and lab automation applications. The company utilizes its multidisciplinary expertise and 30 years of experience to produce and maintain high-quality, complex medical systems such as clinical chemistry analyzers, surgical irrigation pumps, hemodialysis instruments and therapeutic cell processors.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018